There are now more options for COVID-19 testing as US Food and Drug Administration gave emergency use authorisation on April 13 for a saliva-based test. This provides an alternative to the swab testing currently performed.
According to an infectious disease and pandemic preparedness at Johns Hopkins University, who works on and is not involved with the development of the test , Dr. AmeshAdalja “You want to be in all types of situations with all types of options so that we can have as much testing as possible in whatever form is suitable.”
Currently, testing for COVID-19 involves a healthcare professional inserting a swab into each nostril, one at a time, to the nasopharynx at the back of the nasal cavity, gently scraping the tissue to collect material, and sending off for analysis.
Dr. Davis Health says this method is cumbersome as it needs to be done by a qualified worker wearing fresh gloves and other personal protective equipment (PPE), which are in short supply. Additionally, many areas are experiencing a lack of tests available or a large backlog of samples to process.
The collection of a saliva sample requires spitting into a tube, resulting in a much less invasive procedure without tying up large amounts of PPE. Per the Food and Drug Administration’s (FDA) instructions, the testing would still occur in a healthcare setting under the supervision of a qualified professional.
“Saliva testing will help with the global shortage of swabs for sampling and increase testing of patients, and it will not require health care professionals to be put at risk to collect samples,” Andrew Brooks, the chief operating officer of RUCDR Infinite Biologics, a biorepository backed by Rutgers University that developed the spit test, explains in a statement.
The saliva test builds on the existing TaqPath SARS-CoV-2 Assay used in existing COVID-19 testing to identify RNA from the virus.
Brooks explains that in addition to identifying carriers of the virus, this form of testing could also make it easier to re-test people who have recovered so they can end their isolation.
According to validation results provided to the FDA, 60 patient samples taken from saliva and swab tests were in agreement as to the presence of the coronavirus. The agency notes that independent testing by the New Jersey State Health Department of 10 samples agreed with RUCDR’s findings.
But reports say that the saliva tests could be given to patients as soon as today. Until further notice, the tests can only be administered by RUCDR in New Jersey.